Sydney Research
Sydney Research Strategic Plan

Our Executive Director

Our Program Manager

Our Partners
 

Our Partners

 

ANZAC Research Institute has a primary focus on ageing and translational research. ANZAC aims to coordinate the highest quality innovative research at all levels including public and population health, clinical, translational, molecular physiology and cell and molecular biology. The ANZAC Institute has major groups in Andrology, Biogerontology, Bone Biology, Burns Research and Reconstructive Surgery, Cancer & Immune Therapeutics, Dendritic Cell Biology, Geriatric Epidemiology, Northcott Neurobiology Laboratory and Vascular biology. The ANZAC Institute has a strong commitment to translational research and supporting hospital-based research.

The Asbestos Diseases Research Institute (ADRI) is a stand-alone research facility dedicated to asbestos-related diseases, which aims to improve the diagnosis and treatment of asbestos-related diseases and at the same time contribute to more effective measures to prevent exposure to asbestos. ADRI’s research is focused on basic, clinical, public and occupational health, and epidemiological aspects of asbestos-related diseases. A mesothelioma biobank has been established to support translational research. ADRI has strong links with RPAH, Concord Hospital and the Cancer Institute NSW through the Australian Mesothelioma Registry and is continuing to develop international collaborations.

The Baird Institute is the only dedicated cardiothoracic surgical training and research institute in Australia. At The Baird Institute, we identify the issue with the patient, we design relevant research programs that answer specific patient problems, we undertake research in the wards of major teaching hospitals or in affiliated research laboratories and then we return to the operating theatre, intensive care unit and the wards with lifesaving solutions. Our research model is a translational one.  As an organisation, we focus on the translation of quality cutting edge research into improved surgical practise, thus delivering long-term public health solutions.

The University of Sydney’s Brain and Mind Centre takes a patient-centred approach to understanding and treating conditions of the brain and mind. We bring people together, integrating our clinical practice and research to pioneer new systems of care.

We are a global leader in research and treatment. In particular, we focus on conditions that affect child development, youth mental health and brain ageing. We aim to understand individual circumstances and to develop solutions that improve the quality of life for both patients and their loved ones.

The Brain and Mind Centre is a key partner of Sydney Local Health District. We work together to provide the best outcomes for people affected by brain and mind disorders. Visit http://sydney.edu.au/brain-mind/ for more information.

The Centenary Institute is a world-leading, independent Medical Research Institute, dedicated to understanding disease and finding cures for the most chronic diseases affecting our society today. Researchers are focused on three key areas including cancer, cardiovascular disease and inflammation, which is the driver of most diseases. Centenary is located  on the border of the University of Sydney Campus and the Royal Prince Alfred Hospital. With many members of our Faculty being professors and clinicians, we are well-positioned to ensure a virtuous cycle of bed to bench to bed and translate our cutting edge research into practice.

The Centre for Education and Research in Ageing (CERA) links with the ANZAC Institute, the aged care services and Concord Repatriation General Hospital. CERA is aligned with the Sydney Local Health District and the University of Sydney. Research areas include ageing in men, liver disease and ageing, dementia, medications, disability and healthy ageing.

The University of Sydney’s Charles Perkins Centre aims to ease the burden of obesity, diabetes and cardiovascular disease by translating the work of the University of Sydney into real-world solutions. It brings together outstanding academics and practitioners from within the University and beyond to collaborate and forge innovative research partnerships and develop research programs that generate major shifts in our understanding of these diseases and their treatment. The Centre's activities are intimately linked with the NSW Health networks through the University's long standing collaborative partnerships across metropolitan Sydney and regional NSW. It has nodes radiating from its historic Camperdown campus all the way to Broken Hill.

 

The Chris O'Brien Lifehouse is a not-for-profit cancer centre offering care from diagnosis, treatment and to wellness. It is the leading cancer centre in Australia for clinical trials and technology, enabling patients access to some of the world's newest, cutting-edge and lifesaving drugs and procedures. The inpatient facilities deliver 125 overnight beds, including an intensive care unit, and 10 digitalised operating theatres, all using state-of-the-art technology to provide world class care for patients. The centre is open to both public and private patients, and each year Lifehouse has over 130,000 clinical interactions with patients from across Australia. 

The Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP) is based at Concord Hospital and the Charles Perkins Centre as a cooperative venture between the Sydney Local Health District and the University of Sydney. ccCHiP clinics were first established in 2008 to improve the physical health of people with mental illness.  ccCHIP provides innovative clinical models that are replicable and scalable within health services. Clinics operate in an integrated and interdisciplinary approach providing screening, detection, management and follow-up of metabolic disorders among patients with severe mental illness.

The George Institute for Global Health conducts clinical, population and health system research aimed at changing health practice and policy worldwide. Established and headquartered in Australia and affiliated with UNSW Sydney, the Institute today also has offices in China, India and the United Kingdom, and is also affiliated with Peking University Health Science Centre, and the University of Oxford.  Its research has resulted in changes to medical guidelines and ways of thinking about some of the most common medical treatments around the world.

The Heart Research Institute is a world-class institute and hub for scientific excellence in cardiovascular research. Our scientists are at the forefront of ground-breaking research to prevent, detect and treat the world’s number one killer – cardiovascular disease. Each of our research groups investigates a different aspect, from risk factors to innovative medical device technology to disease complications.

Primary  health  networks  have  been  established  with  the  key  objectives  of  increasing  the efficiency and effectiveness of medical services for individuals, particularly those at risk of poor health outcomes. Our vision is supporting, strengthening and shaping a world class, person centred primary health care system. We work to achieve this by working directly with all key players including general practitioners, allied health, nurses, secondary care providers, Local Health Districts and Specialty Health Networks, local communities  and non-government organisations to ensure improved health outcomes for people living and working in our region.

The NHMRC Clinical Trials Centre (CTC) 
CTC is an academic research organisation and is one of Australia’s preeminent clinical trials centres. Over the last three decades, CTC’s research has revolutionised the evidence available to support and influence clinical practice in the areas of cardiovascular disease, diabetes, neonatal health and a broad range of cancers.

The Centre’s mission is to embed high quality clinical trials research into healthcare. By working in consultation with patients, carers, and support networks, and in collaboration with networks of medical research communities, nationally and internationally, CTC achieves better focus and more relevant results to drive evidence into practice.

RPA Institute of Academic Surgery (IAS)  was established in 2014 to become the primary hub of surgical research and education at Royal Prince Alfred Hospital and aims to be at the forefront of leading surgical practice and patient care through the implementation of innovative models and the support of surgical departments. The Institute is a collaboration between Sydney Local Health District and The University of Sydney, and has emerged as the first hospital based Institute of its kind in Australia to focus solely on academic surgery.

 

The Surgical Outcomes Research Centre (SOuRCe) is a multidisciplinary, not for profit, academic research unit of Sydney Local Health District and the University of Sydney dedicated to the advancement of evidence-based surgical practice through the conduct of outcomes-oriented surgical research. SOuRCe promotes the application of clinical trials, health services evaluation, surgical outcomes assessment including quality of life assessment, health economic assessment and methods to facilitate evidence-based patient choice to surgical operations and diagnostic tests related to surgery. SOuRCe has a strong focus on surgical oncology and provides education and training for surgeons in evidence-based medicine and research methods.

Sydney Local Health District (SLHD) hosts world leading biomedical, clinical, health services and public health research across a number of hospital and community services. This includes Royal Prince Alfred, Concord, Canterbury and Balmain Hospitals as well as the Department of Forensic Medicine, RPA Institute of Academic Surgery, Community Health, Mental Health, Oral Health, Population Health and Drug Health Services. The translation of research findings to improved patient care is a central objective of SLHD which is facilitated by the proximity and close linkages with partner agencies.

Since 1850, scholars and students at the University of Sydney have shared a passionate commitment to the transformative power of research and education. The University of Sydney is home to a number of interdisciplinary research centres that have important collaborations with SLHD, including the Charles Perkins Centre, the Brain and Mind Research Institute and the NHMRC Clinical Trials Centre.
The University's collaborative work with SLHD benefits from its work with other independent affiliated medical research institutes associated with SLHD, including the ANZAC Research Institute, the Centenary Institute of Cancer Medicine and Cell Biology, the Heart Research Institute, the Woolcock Institute of Medical Research and the  George Institute for Global Health. 

The Woolcock Institute of Medical Research is one of the world's leading respiratory and sleep research organisations. The Sydney-based institute has over 200 medical researchers working to uncover the causes of disease and find better treatments for a range of health conditions including asthma, allergies, COPD, lung fibrosis, LAM (Lymphangioleiomyomatosis), tuberculosis and sleep disorders. Our research expertise spans the whole medical field from diagnosis and molecular biology through to drug delivery, patient care and education. We are determined that our work creates a better life for people living with lung conditions and sleep disorders.